Thinking the same thing.
$7.7ml is a good reason not to get the Government off side.
Just hope the Government have got it right throwing so many $$$$ to SPL over all these years.
As frustrating as Viraleze is, DEP is still the main game.
Trial results due mid year, unless off course they are delayed AGAIN.
In the mean time i still think Viraleze has potential.
Good results from Vietnam and positive Scripps Institute testing against the Omicron Virus may be the catalyst to progress Viraleze.
Ann: Starpharma receives $7.7M R&D tax incentive refund, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |